These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 7867084
1. Natural killer cells inhibit the development of autoantibody production in (C57BL/6 x DBA/2) F1 hybrid mice injected with DBA/2 spleen cells. Harada M, Lin T, Kurosawa S, Maeda T, Umesue M, Itoh O, Matsuzaki G, Nomoto K. Cell Immunol; 1995 Mar; 161(1):42-9. PubMed ID: 7867084 [Abstract] [Full Text] [Related]
2. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice. Van Rappard-Van Der Veen FM, Radaszkiewicz T, Terraneo L, Gleichmann E. J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176 [Abstract] [Full Text] [Related]
7. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. Nakajima A, Hirose S, Yagita H, Okumura K. J Immunol; 1997 Feb 01; 158(3):1466-72. PubMed ID: 9013993 [Abstract] [Full Text] [Related]
8. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations. Evans R, Fuller JA, Christianson G, Krupke DM, Troutt AB. Cell Immunol; 1997 Jul 10; 179(1):66-73. PubMed ID: 9259773 [Abstract] [Full Text] [Related]
10. Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model. Alici E, Konstantinidis KV, Sutlu T, Aints A, Gahrton G, Ljunggren HG, Dilber MS. Exp Hematol; 2007 Dec 10; 35(12):1839-46. PubMed ID: 18036444 [Abstract] [Full Text] [Related]
11. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression. Kubota E, Ishikawa H, Saito K. J Immunol; 1983 Sep 10; 131(3):1142-8. PubMed ID: 6604089 [Abstract] [Full Text] [Related]
12. Local and systemic immune response to inactivated Candida albicans in mice. Scaringi L, Rosati E, Cornacchione P, Fettucciari K, Sabatini R, Biondi R, Mezzasoma L, Valiani M, D'Errico P, Marconi P. Nat Immun; 1995 Sep 10; 14(5-6):234-49. PubMed ID: 8933818 [Abstract] [Full Text] [Related]
13. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti FW, Murphy WJ. J Clin Invest; 1998 May 01; 101(9):1835-42. PubMed ID: 9576746 [Abstract] [Full Text] [Related]
14. Mechanism of loss of natural killer activity in P815 ascites tumor bearing DBA/2 mice. Saxena RK, Saxena QB, Adler WH. Nat Immun Cell Growth Regul; 1998 May 01; 3(1):34-42. PubMed ID: 6235448 [Abstract] [Full Text] [Related]
15. Natural killer (NK) cells and graft-versus-host disease (GVHD): no correlation between the NK cell levels and GVHD in the murine P----F1 model. Varkila K, Hurme M. Immunology; 1985 Jan 01; 54(1):121-6. PubMed ID: 3972429 [Abstract] [Full Text] [Related]
16. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease. Miyakawa R, Miyaji C, Watanabe H, Yokoyama H, Tsukada C, Asakura H, Abo T. Eur J Immunol; 2002 Sep 01; 32(9):2521-31. PubMed ID: 12207336 [Abstract] [Full Text] [Related]
17. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells. Bohn E, Autenrieth IB. J Immunol; 1996 Feb 15; 156(4):1458-68. PubMed ID: 8568248 [Abstract] [Full Text] [Related]